- Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
-
Yoo SH, Jang JW, Kwon JH, Jung SM, Jang B, Choi JY
- KMID: 2373150
- Clin Mol Hepatol.
- 2016 Dec;22(4):458-465.
- doi: 10.3350/cmh.2016.0054
BACKGROUND/AIMS: Hepatic damage during transarterial chemoembolization (TACE) is a critical complication in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Apart from its role in preventing HBV reactivation, there... -
- CITED
-
- Close
- SHARE
-
- Close
